Anna Narezkina, MD
Cardiovascular Disease · la Jolla, CANPI 1891958773
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,995 of the $14,102 with a category attached, or 92.1%. 10 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 47.8% of the total. Reporting peaked in 2021 at $8,045 and has fallen 98.3% since, to $137 in 2025.
Across 21 payments — averaging $671.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$7K
- Pharmacyclics LLC, An Abbvie Company$5K
- Abbott$2K
- Braemar Manufacturing, LLC$231
- Kestra Medical Technology Services, Inc.$166
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$153
- plus $285 from 4 others
Across 7 payments — averaging $13,804 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ionis Pharmaceuticals, Inc.$66K
- Heartflow, Inc.$28K
- Novartis$3K
What the payments were for
- Consulting fees$12,99592%
- Travel & lodging$1441%
- Food & beverage$9637%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 7 | $6,742 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $4,725 |
| Abbott | 1 | $1,800 |
| Braemar Manufacturing, LLC | 1 | $231 |
| Kestra Medical Technology Services, Inc. | 2 | $166 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $153 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Boston Scientific | 1 | $118 |
| Scpharmaceuticals Inc. | 1 | $30 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMBRUVICA$11,195
- Architect$1,800
- Cardiac Monitoring Suite$231
- ONPATTRO$122
- Watchman$118
- LifeVest$107
- Assure WCD$100
How this compares
$14,102 in reported general payments places this provider in the 80th percentile of 2,184 cardiovascular disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 312 | $414,426 |
| JardianceEmpagliflozin | 340 | $410,651 |
| EntrestoSacubitril/Valsartan | 123 | $186,787 |
| Repatha SureclickEvolocumab | 69 | $89,715 |
| FarxigaDapagliflozin Propanediol | 58 | $62,023 |
| Praluent PenAlirocumab | 45 | $41,013 |
| XareltoRivaroxaban | 21 | $29,304 |
| VascepaIcosapent Ethyl | 32 | $27,621 |
| OzempicSemaglutide | 19 | $23,457 |
| Repatha SyringeEvolocumab | 22 | $22,557 |
| TrulicityDulaglutide | 23 | $20,669 |
| Repatha PushtronexEvolocumab | 11 | $11,265 |
| Rosuvastatin Calcium | 570 | $11,205 |
| Atrovent HfaIpratropium Bromide | 16 | $6,790 |
| Metoprolol Succinate | 411 | $6,443 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in la Jolla
- Eric Topolla Jolla$2.2M
- Pam Taubla Jolla$1.2M
- Douglas Gibsonla Jolla$727K
- Douglas Triffonla Jolla$176K
- Judith Swainla Jolla$151K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Cathleen Bairey-MerzLos Angeles$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.